Addex Therapeutics Ltd

    Jurisdiction
    Switzerland
    LEI
    89450068Y9KVP2MQGH86
    ISIN
    CH0029850754 (ADXN.SW)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €184.68K
    Gross margin
    100.0%
    EBIT
    -€2.79M
    EBIT margin
    -1,508.2%
    Net income
    €9.38M
    Net margin
    5,081.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    N/A N/A
    N/A N/A
    N/A N/A

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: April 25, 2025

    Add to watchlist

    Notifications